<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03414268</url>
  </required_header>
  <id_info>
    <org_study_id>AIPF007</org_study_id>
    <nct_id>NCT03414268</nct_id>
  </id_info>
  <brief_title>Micronized dHACM Injectable for the Treatment of Plantar Fasciitis</brief_title>
  <official_title>A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MiMedx Group, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MiMedx Group, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as
      compared to the saline placebo injection in the treatment of plantar fasciitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 164 patients will be enrolled in this study. Each patient will receive 1
      injection and be evaluated for efficacy and safety during a 6-month observation period.
      Randomization will be 1:1. The study is expected to be completed within 24 months, inclusive
      of enrollment and follow-up of all subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in VAS score</measure>
    <time_frame>90 Days</time_frame>
    <description>Visual Analog Scale for Pain:</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>180 Days</time_frame>
    <description>The incidence of related Adverse Events (AEs), Serious Adverse Events (SAEs), and Unanticipated Adverse Events during the first 12 months post injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Foot Function Index - Revised (FFI-R) (Short Form)</measure>
    <time_frame>90 Days</time_frame>
    <description>Foot Function Index - Revised: Patient Reported Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Fasciitis, Plantar</condition>
  <arm_group>
    <arm_group_label>Micronized dHACM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mL injection of 40 mg Micronized dehydrated human amnion/chorion membrane (dHACM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline Injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Injection of 1mL 0.9% Sodium Chloride Injection, USP</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Micronized dHACM</intervention_name>
    <description>1 mL injection of 40 mg Micronized dehydrated human amnion/chorion membrane (dHACM)</description>
    <arm_group_label>Micronized dHACM</arm_group_label>
    <other_name>dHACM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline Injection</intervention_name>
    <description>Injection of 1mL 0.9% Sodium Chloride Injection, USP</description>
    <arm_group_label>Saline Injection</arm_group_label>
    <other_name>0.9% NaCl</other_name>
    <other_name>Normal Saline</other_name>
    <other_name>Sodium Chloride Injection, USP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed diagnosis of plantar fasciitis for ≥ 1 month (30 days) and ≤ 18 months by
             the investigator

          2. VAS Pain scale of ≥ 45 mm at randomization

          3. Plantar fasciitis with conservative treatment for ≥ 1 month (30 days), including any
             of the following modalities:

               -  RICE

               -  Stretching exercises

               -  NSAIDs

               -  Orthotics

          4. Diagnostic X-Ray within 6 months of enrollment showing view of calcaneus negative for
             calcaneal fracture or structural abnormalities

          5. BMI ≤ 40 kg/m2

          6. Age ≥ 21 years and &lt; 80 years

          7. Ability to sign Informed Consent and Release of Medical Information Forms

          8. Ability to receive and respond to text messages or emails on a daily basis.

        Exclusion Criteria:

          1. Prior surgery or trauma to the affected site

          2. Subjects requiring bilateral plantar fasciitis treatment at time of enrollment

          3. Prior use of any lower limb injection therapy, including corticosteroids or PRP in
             either limb within the last 3 months

          4. Has diabetes either Type I or Type II.

          5. Systemic disorders associated with enthesopathy (disorder of entheses, i.e. bone
             attachments) such as Gout, Reiter's syndrome, rheumatoid arthritis, etc.

          6. The presence of diagnosed comorbidities that can be confused with or can exacerbate
             the condition- to be assessed by X-ray - including but not limited to:

               -  Calcaneal stress fracture

               -  Nerve entrapment syndrome (diagnosed as Baxter Nerve Syndrome)

               -  Fat pad atrophy

               -  Acute traumatic rupture of the plantar fascia

               -  Calcaneal tumor

               -  Tarsal tunnel syndrome (diagnosed)

               -  Significant bone deformity of the foot that may interfere with the study

          7. Affected site exhibits clinical signs and symptoms of infection

          8. Known allergy or known sensitivity to Aminoglycosides

          9. Subjects who are non-ambulatory

         10. History of more than 14 days treatment with immuno-suppressants (including systemic
             corticosteroids) or cytotoxic chemotherapy within 30 days prior to enrollment, or who
             are anticipated to require such medications during the course of the study

         11. Prior radiation at the site

         12. Use of any investigational drug(s) or therapeutic device(s) within 3 months preceding
             enrollment

         13. Immune disorders including Systemic Lupus Erythematosus (SLE), Fibromyalgia, Acquired
             Immunodeficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV)

         14. History of any condition (including drug or alcohol abuse, medical or psychiatric
             condition) that is likely to impair understanding of or compliance with the study
             protocol, in the judgment of the investigator

         15. Pregnancy at enrollment or within last 6 months, women who are breastfeeding, or women
             of childbearing potential who are planning to become pregnant during the time of the
             study OR are unwilling/unable to use acceptable methods of contraception (birth
             control pills, barriers, or abstinence)

         16. Workers' compensation subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart D Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MedStar Union Memorial Hospital, Baltimore, MD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stanley J Harris</last_name>
    <phone>770-651-9100</phone>
    <email>sharris@mimedx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Don Fetterolf, MD</last_name>
    <phone>770-651-9100</phone>
    <email>dfetterolf@mimedx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Phyllis Houston</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>4548</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>ILD Research Center</name>
      <address>
        <city>Carlsbad</city>
        <state>California</state>
        <zip>92009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Vayser</last_name>
      <phone>760-350-5080</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Limb Preservation Platform, Inc.</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Destiny Stegall</last_name>
      <phone>559-431-1700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foot and Ankle Clinic</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Machado, MA</last_name>
      <phone>213-365-0793</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Five Cities Foot Clinic</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghan O'Carroll</last_name>
      <phone>805-481-9100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bay Pines VA Healthcare System</name>
      <address>
        <city>Bay Pines</city>
        <state>Florida</state>
        <zip>33744</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lea Wescott, BA</last_name>
      <phone>727-398-6661</phone>
      <phone_ext>10791</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doctors Research Network</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Garcia, BS</last_name>
      <phone>305-662-1444</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terri Lopez</last_name>
      <phone>504-842-8751</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Foot &amp; Ankle Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89119</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Dove</last_name>
      <phone>702-696-9005</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Orthopedics Center</name>
      <address>
        <city>Altoona</city>
        <state>Pennsylvania</state>
        <zip>16602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Penny Adams, LPN</last_name>
      <phone>814-944-4532</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Penn Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathryn A. Duffill, BS</last_name>
      <phone>412-688-7910</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Orthopedics Center</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sue Jepson, RN</last_name>
      <phone>814-272-3751</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Futuro Clinical Trials, LLC</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jessica Rodriguez</last_name>
      <phone>956-999-8399</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Endeavor Clinical Trials</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terri Ryan, RN</last_name>
      <phone>210-949-0807</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Podiatry</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23464</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen McGee</last_name>
      <phone>747-523-0414</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2018</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic plantar fasciitis</keyword>
  <keyword>Heel pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

